The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer
- 1 January 2000
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 85 (1) , 125-129
- https://doi.org/10.1046/j.1464-410x.2000.00350.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- DIFFERENTIAL EXPRESSION OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS IN HIGH VERSUS LOW GLEASON SCORE PROSTATE CANCERJournal of Urology, 1998
- Prostate-cancer link sours IGF-1Nature Biotechnology, 1998
- Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent MechanismJournal of Biological Chemistry, 1997
- The Effects of Growth Factors Associated with Osteoblasts on Prostate Carcinoma Proliferation and Chemotaxis: Implications for the Development of Metastatic Disease*Endocrinology, 1997
- Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.Proceedings of the National Academy of Sciences, 1996
- Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).Endocrinology, 1995
- The IGF Axis in the ProstateHormone and Metabolic Research, 1994
- Insulin‐like growth factor I: Action and receptor characterization in human prostate cancer cell linesThe Prostate, 1993
- Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*Journal of Clinical Endocrinology & Metabolism, 1991
- Cell Proliferation in CarcinogenesisScience, 1990